Flora Growth Corp. (NASDAQ:FLGC) Q4 2022 Earnings Conference Call April 3, 2023 8:00 AM ET
Company Participants
Jessie Casner - Chief Marketing Officer
Luis Merchan - Chairman & Chief Executive Officer
Elshad Garayev - Chief Financial Officer
Conference Call Participants
Aaron Grey - AGP
Jessie Casner
[Abrupt Start] Before we begin, I'd like to note that the webcast is being recorded and will be published for viewing shortly after the end of the webcast. On the call with me today are Luis Merchan, Chief Executive Officer and Chairman of the Board; as well as Elshad Garayev, Chief Financial Officer.
Today, we'll be discussing the results of fiscal year 2022. Once we complete our prepared remarks, we'll begin the Q&A session, please feel free to use the Q&A function within the webcast. On Friday, March 31, our audited financial statements and earnings release for the period ended December 31, 2022 were filed with the SEC under the cover of a Form 10-K. Copies of both can be found in the Investor Relations section of Flora's website and on EDGAR.
I'd like to remind you that during this webcast, management's prepared remarks may contain forward-looking statements, which are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. For a detailed description of the factors that could cause our actual results or business to differ materially from any forward-looking statements made, please see our 10-K. The company undertakes no obligation to publicly correct or update the forward-looking statements made during the presentation to reflect future events or circumstances, except as may be required under applicable securities law.
In addition, today's call, Flora will refer to certain non-U.S. GAAP financial measures, such as adjusted EBITDA, adjusted gross profit and adjusted gross margin, which do not have any standardized meaning prescribed by U.S. GAAP. Please refer to our filing for the calculation of these measures and reconciliation to the most directly comparable measures calculated and presented in accordance with U.S. GAAP. These non-U.S. GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to and should not be considered in conjunction with the U.S. GAAP financial measures presented in our financial statements. We'd also like to note that all previous filings were reported under IFRS and included non-IFRS measures such as adjusted EBITDA. We may reference and compare to previously reported IFRS-based results.